Contact your GP if taste changes prevent adequate food or fluid intake, cause unintentional weight loss beyond treatment goals, accompany severe abdominal pain, or significantly affect your quality of life
To navigate the GLP-1 era with confidence, companies will need research that answers sharper questions, such as: Which consumer segments are adopting GLP-1s fastest-and why
Patients report experiencing reduced hunger, earlier feelings of fullness, fewer cravings for calorically dense foods, increased energy levels, and improvements in blood pressure, cholesterol, and blood sugar
Calcium: Reduced food intake often means reduced calcium intake
2023;388:e22
Hari Shankar and Om Prakash Shukla upheld a December 2025 single-judge order, observing that Novo Nordisk's species patent appeared "susceptible to revocation on grounds of obviousness." The court noted that semaglutide would be obvious from teachings contained in Novo's earlier genus patent, which expired in 2024